Trial intelligence / Profile preview

Ibandronate vs Placebo in Hip Osteonecrosis Stage 1 and 2

NCT02114489Phase 3Terminated

Start
Jun 2014
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibandronate in osteonecrosis of the femoral head (ONFH). Started Jun 2014; status: terminated.

02

Drugs

ibandronate
03

Conditions

osteonecrosis of the femoral head (ONFH)

Beyond the preview

Go deeper on NCT02114489.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02114489.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call